The effect of Gu-Sui-Bu (Drynaria fortunei) on bone cell activity

American Journal of Chinese Medicine

Volumn 32, Issue 5, 2004, Pages 737-753

  Sun, Jui Sheng ^a   Thériault, Brigitte L ^b   Anderson, Gail I ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Chinese medicine; Drynaria fortunei; Gu Sui Bu; Osteoblasts; Osteoclastogenic stimulus; Osteoclasts

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; CYTOKINE; DRYNARIA FORTUNEI EXTRACT; ESTRADIOL; GENISTEIN; NARINGENIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PROPINQUALIN; PROSTAGLANDIN; UNCLASSIFIED DRUG; GU SUI BU; GU-SUI-BU; HERBACEOUS AGENT;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BONE CELL; BONE MARROW CELL; BONE MINERALIZATION; CELL ACTIVITY; CELL COUNT; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; DOSE RESPONSE; DRUG ISOLATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG STRUCTURE; DRYNARIA FORTUNEI; FEMALE; FERN; IN VITRO STUDY; LOW DRUG DOSE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROSTAGLANDIN RELEASE; RABBIT; ANIMAL; BONE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM;

ANIMALS; BONE AND BONES; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOENZYME TECHNIQUES; MICE; OSTEOCLASTS; RABBITS;

EID: 21744441119     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X0400234X     Document Type: Article

References (35)

1. Anderson, G.I., R. MacQuarrie, C. Osinga, Y.F. Chen, M. Langman and R. Gilbert. Inhibition of leukotriene function can modulate particle-induced changes in bone cell differentiation and activity. J. Biomed. Mater. Res. Appl. Biomater. 58: 406-414, 2001.
2. Arnold, M.D. and L.M. Thornbrough. Treatment of musculoskeletal pain with traditional Chinese herbal medicine. Phys. Med. Rehabil. Clin. N. Am. 10: 663-671, ix-x, 1999.
3. Bellows, C.G., J.E. Aubin and J.N. Heersche. Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 121: 1985-1992, 1987.
4. Brandstrom, H., T. Bjorkman and O. Ljunggren. Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells. Biochem. Biophys. Res. Commun. 280: 831-835, 2001.
5. Burstone, M. Histochemical observation on enzymatic processes in bone and teeth. Ann. New York Acad. Science. 85: 431-444, 1960.
6. Chambers, T.J., P.A. Revell, K. Fuller and N.A. Athanasou. Resorption of bone by isolated rabbit osteoclasts. J. Cell Sci. 66: 383-399, 1984.
7. Chan, K. Progress in traditional Chinese medicine. Trends Pharmacol. Sci. 16: 182-187, 1995.
8. Cheng, J. Drug therapy in traditional medicine. Clin. Pharmacol. 40: 445-450, 2000.
9. Fanti, P., M.C. Monier-Faugere, Z. Geng, J. Schmidt, P.E. Morris, D. Cohen and H.H. Malluche. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos. Int. 8: 274-281, 1998.
10. Friedrich, M. Chinese and US health care leaders discuss challenges of the 21st century. J. Am. Med. Assoc. 286: 659-661, 2001.
11. Gardner, C.R., R. Blanque and C. Cottereaux. Mechanisms involved in prostaglandin-induced increase in bone resorption in neonatal mouse calvaria. Prostaglandins Leukot. Essent. Fatty Acids 64: 117-125, 2001.
12. Hunter, D.S., L.C. Hodges, P.M. Voiner, R. Fuchs-Young, M.M. Gottardis and C.L. Walker. Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium. Cancer Res. 59: 3090-3099, 1999.
13. Khosla, S. Minireview: The OPG/RANKL/RANK system. Endocrinology 142: 5050-5055, 2001.
14. Kim, H.J., Y.C. Bae, R.W. Park, S.W. Choi, S.H. Cho, Y.S. Choi and W.J. Lee. Bone-protecting effect of safflower seeds in ovariectomized rats. Calcif. Tissue Int. 71: 88-94, 2002.
15. Koh, H.L. and S.O. Woo. Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs. Drug Saf. 23: 351-362, 2000.
16. Kurzer, M.S. and X. Xu. Dietary phytoestrogens. Annu Rev. Nutr. 17: 353-381, 1997.
17. Lee, K.H. Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine. Public Health Nutr. 3: 515-522, 2000.
18. Lin, C.Y., J.S. Sun, S.Y. Shen, F.H. Lin, Y.J. Wang and L.T. Chen. The effect of Chinese medicine on bone cell activities. Am. J. Chin. Med. 30: 271-285, 2002.
19. Liu, H.C., R.M. Chen, W.C. Jian and Y.L. Lin. Cytotoxic and antioxidant effects of the water extract of the traditional Chinese herb gusuibu (Drynaria fortunei) on rat osteoblasts. J. Formos. Med. Assoc. 100: 383-388, 2001.
20. Liu, S.Q., Z.Y. Xiao and R. Feng. Chemical constituents of Drynaria propinqua (Wall) J. Sm. Zhongguo Zhong Yao Za Zhi 17: 737-739, 763, 1992.
21. Ma, K.C., T.Y. Zhu and F.X. Wang. Stimulative effects of gusuibu (Drynaria baronii) injection on chick embryo bone primordium calcification in vitro. Am. J. Chin. Med. 24: 77-82, 1996.
22. Ma, Z., R. Wang and M. Qiu. Study of morphologic effects of four Chinese herbs by bone histomorphometry in ovariectomized rats. Zhonghua Fu Chan Ke Za Zhi 34: 82-85, 1999.
23. Majors, A.K., C.A. Boehm, H. Nitto, R.J. Midura and G.F. Muschler. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J. Orthop. Res. 15: 546-557, 1997.
24. Minkin, C. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif. Tissue Int. 34: 285-290, 1982.
25. Mouly, P., E.M. Gaydou and J. Estienne. Column liquid chromatographic determination of flavanone glycosides in Citrus. Application to grapefruit and sour orange juice adulterations. J. Chromatogr. 634: 129-134, 1993.
26. Nagata, C., H. Shimizu, R. Takami, M. Hayashi, N. Takeda and K. Yasuda. Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in postmenopausal Japanese women. Osteoporosis Int. 13: 200-204, 2002.
27. O'Brien, E.A., J.H. Williams and M. J. Marshall. Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane. Bone 28: 208-214, 2001.
28. Ohta, A., M. Uehara, K. Sakai, M. Takasaki, H. Adlercreutz, T. Morohashi and Y. Ishimi. A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equal production in ovariectomized mice. J. Nutr. 132: 2048-2054, 2002.
29. Prophet, E., B. Mills, J. Arrington and L. Sobin. Laboratory Methods in Histotechnology. American Registry of Pathology, Washington, DC, USA, 1992.
30. Ratna, W.N. and J.A. Simonelli. The action of dietary phytochemicals quercetin, catechin, resveratrol and naringenin on estrogen-mediated gene expression. Life Sci. 70: 1577-1589, 2002.
31. Sun, J.S., C.Y. Lin, G.C. Dong, S.Y. Shen, F.H. Lin, L.T. Chen and Y.J. Wang. The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) on bone cell activities. Biomaterials 23: 3377-3385, 2002.
32. Udagawa, N., N. Takahashi, E. Jimi, K. Matsuzaki, T. Tsurukai, K. Itoh, N. Nakagawa, H. Yasuda, M. Goto, E. Tsuda, K. Higashio, M.T. Gillespie, T.J. Martin and T. Suda. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: Receptor activator of NF-kappa B ligand. Bone 25: 517-523, 1999.
33. Viereck, V., C. Grundker, S. Blaschke, H. Siggelkow, G. Emons and L.C. Hofbauer. Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. J. Cell Biochem. 84: 725-735, 2002.
34. Yamaguchi, M., Z.J. Ma and T. Fushimi. Anabolic effect of phosphogenistein and phosphodaidzein on bone components in rat femoral-metaphyseal tissues in vitro. J. Bone Miner. Metab. 20: 148-155, 2002.
35. Yuan, R. and Y. Lin. Traditional Chinese medicine: An approach to scientific proof and clinical validation. Pharmacol. Ther. 86: 191-198, 2000.